Medicare patients in plans mismatched to their clinical situation cost your practice money and cost your patients their health. Here is the economics of how — how a coverage mismatch becomes bad debt, a missed quality measure, or a lost patient — with every figure linked to its original source.
A patient chooses a Medicare Advantage plan whose cost-sharing structure doesn't fit their clinical reality — a high deductible, coinsurance instead of flat copays, a specialist tier that doesn't match how often they actually need to be seen. Nobody checks the fit against the diagnoses and medications already in the record. The gap surfaces months later, as a balance the patient didn't expect and can't pay.
Medicare Advantage cost-sharing has grown more complex and more front-loaded. Among MA drug plans, the average deductible rose from $62 in 2024 to $224 in 2025, and the share of enrollment in plans charging coinsurance — rather than a fixed copay — for preferred brand drugs jumped from 2.6% to 27.5%. More of the cost, and more unpredictable cost, lands directly on the patient at the point of care.
For a simple office visit, the copay is on the card. But when the plan uses coinsurance instead of a fixed copay, the patient owes a percentage of an allowed amount nobody knows until the claim adjudicates. Add a deductible the front desk can't see the running balance of, plus in-office procedures, labs, injections, and imaging — and the real number lands well past the visit copay. That exposure is precisely what a mismatched plan loads up, and eligibility verification confirms only that the plan is active, never that it fits.
This is where it becomes your problem. Benchmarking data attributes the persistent and widening bad-debt gap between Traditional Medicare and Medicare Advantage specifically to payor behavior — the same cost-sharing complexity, slower adjudication, and higher denial rates described above. Some of that gap is structural to the MA product. But the portion driven by patients placed in plans that never fit their situation is addressable — before the first balance is ever written off.
Eligibility verification answers "is this plan active." It never asks "is this plan right." The bad debt from that unasked question is the most direct, most universal cost of plan mismatch — and the one every practice with Medicare patients already carries.
This is the acute, time-sensitive version of the problem, and 2026 has made it impossible to ignore. When a health system drops a Medicare Advantage plan — or a plan exits the market — the patients in that plan don't vanish. They arrive at your front desk out-of-network, often without knowing they had a window to move, and often after the easiest window has closed.
At least 23 health systems have terminated Medicare Advantage contracts in 2026, citing prior-authorization denials and slow reimbursement. And plan exits are displacing enrollees at an unprecedented rate: roughly 1 in 10 Medicare Advantage enrollees — about 2.9 million people — are being forced to change plans in 2026 as insurers leave their counties.
A peer-reviewed analysis projects forced disenrollment reaching roughly 10% of MA enrollees in 2026, up from about 1% before 2025. State insurance commissioners have formally asked CMS to create a group Special Enrollment Period for members who lose the same major provider — regulatory acknowledgment that this is a distinct, remediable harm, not the individual patient's problem to solve alone.
A displaced patient who doesn't move in time becomes an out-of-network encounter, a disrupted care relationship, and often a lost patient. Many of these patients qualify to move immediately under a Special Enrollment Period rather than waiting for the fall — but only if someone identifies them and acts while the window is open.
When your practice drops a plan, the list of affected patients already exists in your records. The difference between keeping and losing them is whether someone identifies who can move now — versus telling them all to wait until October.
As value-based arrangements expand, more of your reimbursement rides on measures — medication adherence, blood glucose control, blood pressure — that a patient simply cannot hit if their plan has placed their prescribed drug on a tier they won't pay for. Plan design and quality performance are not separate conversations. Get the plan wrong and you are working against your own scores.
Performance on the medication-adherence measures is tightly linked to performance on the intermediate outcomes those measures exist to capture. Plans achieving 5 stars on the diabetes medication-adherence measure were 3.5 times more likely to achieve 5 stars on the controlling-blood-glucose measure.
This is the causal link, not just a correlation: when cost-sharing came down under expanded Low-Income Subsidy eligibility and Part D redesign, cost-related non-adherence fell by 4.9 percentage points overall — and by 7.8 points among patients with two or more chronic conditions. The right plan makes the prescribed drug affordable, and affordability is what moves the measure.
The 2027 Star Ratings set includes Special Needs Plan (SNP) Care Management and Care for Older Adults – Medication Review as scored process measures, alongside a 3×-weighted Controlling Blood Pressure measure. Together, the adherence, statin-process, and Part C intermediate measures account for about 21% of the weighted Star Ratings — and higher Star Ratings drive the quality bonus payments and rebates a plan lives on. A patient placed in a plan built for their condition can gain access to scored measures a standard plan never had to deliver.
You are increasingly paid on whether your patients take their medications and control their conditions. When the plan makes the prescribed drug unaffordable, it is working directly against the number your contract depends on. Correct placement is a quality-measure intervention.
You prescribed the right medication. The wrong plan made it inaccessible. This is the chain that starts as a patient's private financial decision and ends as a clinical event in your exam room — and it is the half of the problem that never shows up on a billing report until it's already expensive.
Roughly a quarter of prescriptions written for Medicare patients are never filled — abandoned at the counter or rejected at the payer, frequently because of cost. The patient never starts the therapy you intended.
Seniors skip doses and stretch prescriptions specifically to save money, and the sicker and lower-income the patient, the more likely they are to do it. They rarely tell you. It surfaces as a control problem you can't explain from the chart alone.
The majority of the cost of non-adherence comes from avoidable hospitalization, with additional cost from disease progression and increased visits to physician offices, emergency rooms, and urgent care. The unfilled prescription becomes the decompensation — and the acute episode is far more expensive, clinically and financially, than the drug ever was.
Non-adherence is often not a discipline problem. For a large share of patients it is a formulary problem — and a formulary problem is solvable at the moment of enrollment, before it becomes the admission you're treating.
Figures are national data drawn from the sources linked above; how much applies to your practice depends on your panel, payer mix, and contracts. Our focus is plan fit — matching a patient to coverage suited to their clinical situation — rather than broader questions of Medicare policy or program design. Patient Coverage Connect flags a likely mismatch from information already in the record; a vetted, licensed advisor reviews the options, explains the benefit design, and handles any change with the patient's documented consent. Fast-moving figures — the count of health systems exiting Medicare Advantage and the number of displaced enrollees — are updated as new data is published.
Across all four chains, the pattern is the same: the diagnosis, the medication list, the plan identifier, the subsidy status — everything needed to spot the mismatch already exists in the record. The gap has never been information. It's that nothing connects that information to the coverage decision while there's still time to act on it. That connection is what Patient Coverage Connect provides.
See how it works for your practice →